Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study.
Morange PE, Tregouet DA, Godefroy T, Saut N, Bickel C, Rupprecht HJ, Lackner K, Barbaux S, Poirier O, Peiretti F, Nalbone G, Juhan-Vague I, Blankenberg S, Tiret L. Morange PE, et al. J Mol Med (Berl). 2008 Oct;86(10):1153-61. doi: 10.1007/s00109-008-0375-6. Epub 2008 Jul 4. J Mol Med (Berl). 2008. PMID: 18600307
Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study.
Fontaine-Bisson B, Alessi MC, Saut N, Fumeron F, Marre M, Dutour A, Badens C, Levy N, Tichet J, Juhan-Vague I, Trégouët DA, Balkau B, Morange PE. Fontaine-Bisson B, et al. Among authors: juhan vague i. J Mol Med (Berl). 2010 Feb;88(2):193-201. doi: 10.1007/s00109-009-0548-y. Epub 2009 Oct 16. J Mol Med (Berl). 2010. PMID: 19841875
Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE, Blankenberg S, Alessi MC, Bickel C, Rupprecht HJ, Schnabel R, Lubos E, Münzel T, Peetz D, Nicaud V, Juhan-Vague I, Tiret L; Atherogene Investigators. Morange PE, et al. J Thromb Haemost. 2007 Mar;5(3):475-82. doi: 10.1111/j.1538-7836.2007.02372.x. Epub 2007 Jan 4. J Thromb Haemost. 2007. PMID: 17204132 Free article.
Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Tregouet DA, Schnabel R, Alessi MC, Godefroy T, Declerck PJ, Nicaud V, Munzel T, Bickel C, Rupprecht HJ, Lubos E, Zeller T, Juhan-Vague I, Blankenberg S, Tiret L, Morange PE; AtheroGene Investigators. Tregouet DA, et al. J Thromb Haemost. 2009 Jan;7(1):49-57. doi: 10.1111/j.1538-7836.2008.03221.x. J Thromb Haemost. 2009. PMID: 19017260 Free article.
The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice: possible contribution to elevated plasma levels of soluble TNF alpha receptors.
Canault M, Peiretti F, Kopp F, Bonardo B, Bonzi MF, Coudeyre JC, Alessi MC, Juhan-Vague I, Nalbone G. Canault M, et al. Atherosclerosis. 2006 Jul;187(1):82-91. doi: 10.1016/j.atherosclerosis.2005.08.031. Epub 2005 Oct 7. Atherosclerosis. 2006. PMID: 16214147
The shedding activity of ADAM17 is sequestered in lipid rafts.
Tellier E, Canault M, Rebsomen L, Bonardo B, Juhan-Vague I, Nalbone G, Peiretti F. Tellier E, et al. Exp Cell Res. 2006 Dec 10;312(20):3969-80. doi: 10.1016/j.yexcr.2006.08.027. Epub 2006 Sep 5. Exp Cell Res. 2006. PMID: 17010968
283 results